NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models.
Saved in:
| Title: | NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models. |
|---|---|
| Authors: | Xu C; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: chunxiao.xu@emdserono.com., Marelli B; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Qi J; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Qin G; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Yu H; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Wang H; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Jenkins MH; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Lo KM; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA., Lan Y; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: yan.lan@emdserono.com. |
| Source: | Translational oncology [Transl Oncol] 2022 Feb; Vol. 16, pp. 101322. Date of Electronic Publication: 2021 Dec 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34954456 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+C%22">Xu C</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: chunxiao.xu@emdserono.com.<br /><searchLink fieldCode="AU" term="%22Marelli+B%22">Marelli B</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Qi+J%22">Qi J</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Qin+G%22">Qin G</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Wang+H%22">Wang H</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Jenkins+MH%22">Jenkins MH</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Lo+KM%22">Lo KM</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA.<br /><searchLink fieldCode="AU" term="%22Lan+Y%22">Lan Y</searchLink>; EMD Serono Research and Development Institute, Inc, 45 Middlesex Turnpike, Billerica, MA 01821, USA. Electronic address: yan.lan@emdserono.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101472619%22">Translational oncology</searchLink> [Transl Oncol] 2022 Feb; Vol. 16, pp. 101322. <i>Date of Electronic Publication: </i>2021 Dec 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Neoplasia+Press%22">Neoplasia Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101472619 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1936-5233 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219365233%22">19365233 </searchLink><i>NLM ISO Abbreviation: </i>Transl Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34954456 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.tranon.2021.101322 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101322 Titles: – TitleFull: NHS-IL12 and bintrafusp alfa combination therapy enhances antitumor activity in preclinical cancer models. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu C – PersonEntity: Name: NameFull: Marelli B – PersonEntity: Name: NameFull: Qi J – PersonEntity: Name: NameFull: Qin G – PersonEntity: Name: NameFull: Yu H – PersonEntity: Name: NameFull: Wang H – PersonEntity: Name: NameFull: Jenkins MH – PersonEntity: Name: NameFull: Lo KM – PersonEntity: Name: NameFull: Lan Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2022 Feb Type: published Y: 2022 Identifiers: – Type: issn-print Value: 1936-5233 Numbering: – Type: volume Value: 16 Titles: – TitleFull: Translational oncology Type: main |
| ResultId | 1 |